menu
    • menu
    [{"orgOrder":0,"company":"Sandoz B2B","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"SWITZERLAND","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2019","type":"Inapplicable","leadProduct":"Iron III Hydroxide Polymaltose Complex","moa":"Iron","graph1":"Hematology","graph2":"Phase III","graph3":"Sandoz B2B","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Tablet, Chewable","sponsorNew":"Sandoz B2B \/ Undisclosed","highestDevelopmentStatusID":"10","companyTruncated":"Sandoz B2B \/ Undisclosed"},{"orgOrder":0,"company":"Akram Medical Complex","sponsor":"Scotmann Pharmaceuticals | The Searle Company Limited Pakistan","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"PAKISTAN","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"Iron III Hydroxide Polymaltose Complex","moa":"Undisclosed","graph1":"Hematology","graph2":"Undisclosed","graph3":"Akram Medical Complex","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Akram Medical Complex \/ Scotmann Pharmaceuticals | The Searle Company Limited Pakistan","highestDevelopmentStatusID":"1","companyTruncated":"Akram Medical Complex \/ Scotmann Pharmaceuticals | The Searle Company Limited Pakistan"}]

    Find Clinical Drug Pipeline Developments & Deals for teferrol

    Menu

    teferrol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Akram Medical Complex

                            Country arrow
                            AllPack Indonesia
                            Not Confirmed

                            Akram Medical Complex

                            Country arrow
                            AllPack Indonesia
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Iron III Hydroxide Polymaltose Complex

                            Therapeutic Area : Hematology

                            Study Phase : Undisclosed

                            Sponsor : Scotmann Pharmaceuticals | The Searle Company Limited Pakistan

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Hypoferritinemia Without Anemia Among Reproductive Age Females

                            Details : Iron III Hydroxide Polymaltose Complex is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Hypoferritenemia Without Anemia.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            May 31, 2024

                            Lead Product(s) : Iron III Hydroxide Polymaltose Complex

                            Therapeutic Area : Hematology

                            Highest Development Status : Undisclosed

                            Sponsor : Scotmann Pharmaceuticals | The Searle Company Limited Pakistan

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Sandoz B2B

                            Switzerland arrow
                            AllPack Indonesia
                            Not Confirmed

                            Sandoz B2B

                            Switzerland arrow
                            AllPack Indonesia
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Iron III Hydroxide Polymaltose Complex

                            Therapeutic Area : Hematology

                            Study Phase : Phase III

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Study to Test the Hypothesis of Non-inferior Efficacy and Safety of Ferrum Lek® (Iron (III) Hydroxide Polym...

                            Details : Iron Hydroxide Polymaltose is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Anemia, Iron-Deficiency.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            June 20, 2019

                            Lead Product(s) : Iron III Hydroxide Polymaltose Complex

                            Therapeutic Area : Hematology

                            Highest Development Status : Phase III

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth